Ann: Memphasys & Monash IVF commence clinical trial of FELIX, page-15

  1. 168 Posts.
    lightbulb Created with Sketch. 81
    They've been talking about separating sperm since 2014. So it wasn't yesterday this adventure began - if it really is required in the industry, going to be more efficient and save all the big players money - why is no one that interested?

    7 years to make $11k - the $11k being a sale to a Chinese distributor - anyone else worried they'll simply test it, if it works then copy it and roll it out?? Not like these guys are afraid of litigation (which they know MEM can't afford) or patents.

    4 years ago they raised $3.75m to accelerate the commercialization of this product.
    4 years - and only now it's going to Monash (a shareholder) to actually trial it.


    Maybe it works - maybe it's amazing - maybe I'm wrong here.

    Most small caps have a good idea - that's how they convinced people to invest in the first place.
    But the vast majority can't commercialize it and actually make money - so when they fail, the crafty ones change tact, invent some new bullshit idea to keep people keen, and raise more money.

    Have a look at how many announcements around "commercializing the Felix device" there are - any red flags??

    Anyway, I hope you guys make money and I wish everyone well here.
    I'm just sharing the alternative opinion to widen the debate.



    All the best.



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.001(12.5%)
Mkt cap ! $8.926M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $1.125K 250K

Buyers (Bids)

No. Vol. Price($)
21 10399058 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 5759125 8
View Market Depth
Last trade - 11.54am 15/07/2025 (20 minute delay) ?
MEM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.